NASDAQ · Biotechnology

Klotho Neurosciences, Inc. (KLTO) Stock

$0.38 -7.10% NASDAQ: KLTO Healthcare

Klotho Neurosciences, Inc. operates as a biopharmaceutical enterprise focused on devising medical treatments for various conditions, including cancer, cardiovascular ailments, and neurodegenerative disorders.

Valuation

MetricValue
Price$0.38
Market Cap$20.08M
P/E Ratio-1.13
P/B Ratio0.69
P/S Ratio0.00
EPS (TTM)$-0.22
52-Week High$3.91
52-Week Low$0.11
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-108.82%
ROA-37.12%
ROCE-25.47%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.01
Current Ratio19.74

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-1.0M$-1.0M$-6.0M$-7.0M
Net Profit$-1.0M$-1.0M$-1.0M$-6.0M$-11.0M
EPS$0.00$0.00$0.00$-0.32$-0.22
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$3.0M$2.0M$2.0M$10.0M
Total Liabilities$0$1.0M$2.0M$1.0M$0
Cash$0$0$0$0$7.0M
Borrowings$0$1.0M$1.0M$0$0

Latest News

Csquare, Inc. Announces Pricing of Initial Public Offering PR Newswire · Jul 16, 2026 Analysis-China's record consumer defaults undermine Beijing's push to boost spending Reuters · Jul 16, 2026 CSTS Enterprises And Connexus Travel Team Up With Sichuan Airlines Launch Exclusive World Cup-Themed Flights PR Newswire · Jul 16, 2026 RESEARCH ADVANCES FROM THE 2026 ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE PR Newswire · Jul 16, 2026 Lululemon Backs French Recycling Start-up Syntetica in $30 Million Series A Round WWD · Jul 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-1.0M$0$-3.0M$-6.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$1.0M$0
Net Cash Flow$0$0$0$0$7.0M
Free Cash Flow$0$-1.0M$0$-3.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.08
EV / EBITDA-0.67
FCF Yield-47.81%
Quick Ratio19.74
Interest Coverage-5.13
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CVKD $2.06 +0.98% -0.78 $6.38M 0.00%
IBIO $1.45 +1.40% -0.91 $22.89M 0.00%
MTVA $1.42 -1.39% -0.16 $3.13M 0.00%
NERVMinerva Neurosciences, Inc. $4.14 +2.35% -0.14 $28.92M 0.00%
NRSNNeuroSense Therapeutics Ltd. $0.60 -0.35% -1.35 $21.21M 0.00%

About Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. operates as a biopharmaceutical enterprise focused on devising medical treatments for various conditions, including cancer, cardiovascular ailments, and neurodegenerative disorders. Their leading gene therapy assets encompass AMI-101, which is designed for the management or prevention of Alzheimer's disease, and AMI-202, aimed at treating or averting amyotrophic lateral sclerosis. Formerly known as Anew Medical, Inc., the company underwent a name change to Klotho Neurosciences, Inc. in September 2024. The firm's main office is situated in Omaha, Nebraska.

Klotho Neurosciences, Inc. is headquartered in US.

Klotho Neurosciences, Inc. (KLTO) stock trades at $0.38 with a market capitalization of $20.08M. The stock is valued at a price-to-earnings (P/E) ratio of -1.13, price-to-book of 0.69, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.11 and $3.91, and currently trades 90.3% below its 52-week high.

On profitability, Klotho Neurosciences, Inc. generates a return on equity (ROE) of -108.82%, return on capital employed of -25.47%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: klothoneuro.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides